Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells
Open Access
- 4 June 2018
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (11) , 1259-1271
Abstract
Key Points. N-RasG12D and haploinsufficient Tet2 collaborate to induce lethal and highly penetrant CMML in mice with shortened overall survival.N-RasG12D and hKeywords
This publication has 46 references indexed in Scilit:
- Progression of RAS-Mutant Leukemia during RAF Inhibitor TreatmentNew England Journal of Medicine, 2012
- The role of mutations in epigenetic regulators in myeloid malignanciesNature Reviews Cancer, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in miceProceedings of the National Academy of Sciences, 2011
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood, 2009
- Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cellsNature Biotechnology, 2008
- Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdUNature, 2007
- K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsBlood, 2006